You are here: Industry Insights > Merck

News List

Merck to Acquire ArQule americanpharmaceuticalreview
December 12, 2019
Merck and ArQule announced the companies have entered into a definitive agreement under which Merck, through a subsidiary ...
Merck to Acquire ArQule for $2.7B ContractPharma
December 11, 2019
Diversifies oncology pipeline with expansion into targeted therapies that treat hematological malignancies.
Merck to acquire ArQule in $2.7bn deal pharmaceutical-technology
December 11, 2019
Merck (MSD) has signed a definitive agreement to acquire biopharmaceutical company ArQule for a total cash consideration of $2.7bn, or $20 per share.
AstraZeneca-Merck’s Lynparza approved in China for ovarian cancer pharmaceutical-technology
December 09, 2019
AstraZeneca and Merck (MSD) have received the National Medical Products Administration (NMPA) approval in China for Lynparza (olaparib) to treat ...
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial En-CPhI.CN
November 11, 2019
Merck and Pfizer Inc. announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction chemotherapy in patients with unresectable ...
Merck reimagines Keytruda patient support program as it celebrates 5th birthday fiercepharma
September 26, 2019
The Key+You program falls into the typical customer relationship management program, with about 5% of patients involved.
FDA grants priority review for Merck’s Ebola Vaccine biospectrumasia
September 18, 2019
The Prescription Drug User Fee Act (PDUFA), or target action date, is set for March 14, 2020. In July 2016, the FDA granted Breakthrough Therapy Designation to V920.
Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine americanpharmaceuticalreview
September 04, 2019
Merck recently awarded a $500,000 grant to the Smithsonian’s National Museum of American History to use for developing an exhibition and programming on the history of American medicine in recognition of ...
BIO campaign gathers pharma partners to lobby Congress against superbugs fiercepharma
September 02, 2019
Merck, Novo Holdings and several smaller drug developers are partnering with the Biotechnology Innovation Organization (BIO) trade group in a new initiative to spur research and development in the fight against superbugs.
Eisai teams up with Merck to tackle NTDs in Kenya biospectrumasia
August 29, 2019
Eisai seeks to contribute to the health and welfare of people in developing and emerging countries.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page